GATA4

GATA Binding Protein 4: A Master Regulator of Cardiac Development and Function

Gene Information Card

Symbol GATA4
Full Name GATA binding protein 4
Gene Type protein-coding
Chromosomal Location 8p23.1
NCBI Gene ID 2626 ncbi.nlm.nih.gov/gene/2626
Ensembl ID ENSG00000136574
UniProt ID P43694
OMIM ID 600576
HGNC ID 4173
Aliases MGC126629, MGC126631, VSD1

Description

GATA4 is a member of the GATA family of zinc-finger transcription factors that bind the consensus DNA sequence (A/T)GATA(A/G). It is essential for normal cardiac development, including heart tube formation, myocardial differentiation, and septation. GATA4 also plays roles in gonadal development and endodermal differentiation. Mutations in GATA4 are associated with congenital heart defects, particularly atrial and ventricular septal defects.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital heart disease (CHD) Loss-of-function mutations impair GATA4 transcriptional activity, disrupting cardiac morphogenesis and septation. ClinVar, OMIM
Atrial septal defect (ASD) Heterozygous mutations reduce GATA4 binding to target promoters, leading to incomplete atrial septum formation. ClinVar, OMIM
Ventricular septal defect (VSD) Dominant-negative or haploinsufficient GATA4 variants alter downstream gene expression required for ventricular septation. ClinVar, OMIM
Tetralogy of Fallot Rare GATA4 missense variants disrupt protein stability and DNA binding, contributing to outflow tract defects. ClinVar, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Heart 48.3 High
Testis 12.1 Medium
Pancreas 8.5 Medium
Liver 6.2 Low
Lung 4.8 Low
Cell Line Expression
Cell Line nTPM Notes
Cardiomyocytes (iPS-derived) 52.0 High expression in differentiated cardiac cells
HepG2 6.5 Moderate expression in liver carcinoma line
A549 3.2 Low expression in lung carcinoma line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.820G>A (p.Glu274Lys) Missense Rare Reduced DNA-binding affinity and transcriptional activation
c.1075C>T (p.Arg359Trp) Missense Rare Impaired nuclear localization and protein stability
c.1A>G (p.Met1Val) Missense Rare Loss of start codon, leading to haploinsufficiency
c.1114G>A (p.Gly372Ser) Missense Rare Dominant-negative effect on GATA4 target gene expression
Mutation functional classification

Loss of Function (LOF)

Most pathogenic GATA4 mutations result in loss of function via reduced DNA binding, transcriptional activity, or protein stability, leading to haploinsufficiency.

Gain of Function (GOF)

No well-characterized gain-of-function mutations are reported for GATA4 in human disease.

Dominant Negative (DN)

Some missense mutations (e.g., p.Gly372Ser) exert dominant-negative effects by interfering with wild-type GATA4 function, often associated with severe cardiac defects.

Pathways

Cardiac progenitor differentiation (Reactome: R-HSA-5576891)
Transcriptional regulation of pluripotent stem cells (Reactome: R-HSA-913531)
GATA4/NKX2-5 regulatory network in heart development (KEGG: hsa05410)

Protein Summary

GATA4 is a 442-amino acid transcription factor containing two conserved zinc finger domains (N-terminal and C-terminal) that mediate DNA binding and protein-protein interactions. It is highly expressed in the developing heart and adult cardiac tissue. GATA4 cooperates with other cardiac transcription factors (e.g., NKX2-5, TBX5) to regulate genes involved in cardiomyocyte proliferation, differentiation, and survival. Post-translational modifications, including acetylation and phosphorylation, modulate its activity.

Related Products

Product name Cat.No. Species Gene ID
GATA4 Knockout HEK293 Cell Line EDJ-KQ1836 Human 2626 Details Get a Quote
GATA4 Knockout A-549 Cell Line EDJ-KQ21691 Human 2626 Details Get a Quote
GATA4 Knockout HeLa Cell Line EDJ-KQ53308 Human 2626 Details Get a Quote
GATA4 Knockout HCT 116 Cell Line EDJ-KQ70274 Human 2626 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: